Lupin enters skincare segment in Brazil with new products
Lupin, transnational pharmaceutical company has entered into the prescription dermatology segment in Brazil with the launch of two products Fillerina and Recrexina. Fillerina is […]
Say something
Lupin, transnational pharmaceutical company has entered into the prescription dermatology segment in Brazil with the launch of two products Fillerina and Recrexina. Fillerina is […]
[This article was published in the August 2008 issue of the eHEALTH Magazine (https://www.ehealthonline.org)]
Increasingly clinical trials are coming under the regulatory lense because of lack of necessary accounting of the patient and drug effects information. The following article takes a look at the new trends in electronic data capture that help track the data better.